Article info
PDFReview
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review
- Correspondence to Professor P Lanzetta, Department of Ophthalmology, University of Udine, Piazzale S Maria della Misericordia, Udine 33100, Italy; paolo.lanzetta{at}uniud.it
Citation
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review
Publication history
- Received March 12, 2013
- Revised June 14, 2013
- Accepted July 13, 2013
- First published August 8, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions